Americans are relying on unregulated sellers for GLP-1 weight-loss medications.

Americans are relying on unregulated sellers for GLP-1 weight-loss medications.

Concerns Rise Over Unregulated GLP-1 Drug Sales As interest in GLP-1 medications surges, particularly for weight loss and diabetes management, many Americans are opting for unregulated sellers instead of traditional pharmacies. This shift often stems from high costs, insurance issues, and consistent shortages. The FDA has issued warnings regarding the “gray market” for GLP-1 drugs, […]

Weight-loss physician explains how GLP-1 medications also address chronic illness

Weight-loss physician explains how GLP-1 medications also address chronic illness

Recent research indicates that weight loss and diabetes medications, known as glucagon-like peptide-1 receptor agonists (GLP-1), could be beneficial for a range of other health issues. These issues include cardiovascular disease, arthritis, skin conditions, and potentially even cancer prevention. The use of these drugs is linked to a reduced risk of chronic diseases, with a […]

Giving up ultra-processed foods might double your weight-loss success, research indicates

Giving up ultra-processed foods might double your weight-loss success, research indicates

Study Highlights Impact of Eliminating Ultra-Processed Foods on Weight Loss A recent study indicates that avoiding a specific type of food can nearly double the results of weight loss efforts. Published on August 4 in the journal Nature Medicine, it reveals that overweight adults who stopped consuming ultra-processed foods (UPFs) lost almost twice the weight […]

Weight-loss medications associated with higher chances of eye problems and vision impairment

Weight-loss medications associated with higher chances of eye problems and vision impairment

Recent research indicates that some weight loss medications may be linked to a heightened risk of serious eye conditions, including potential vision loss. Two studies featured in Jama examined the effects of semaglutide and tilzepatide—common drugs like Ozempic, Wegovy, Munjaro, and Zepbound—on the eye health of Americans diagnosed with Type 2 diabetes over a two-year […]

Diabetes and weight-loss medications might also help with arthritis symptoms.

Diabetes and weight-loss medications might also help with arthritis symptoms.

The Benefits of GLP-1 Drugs Extend Beyond Diabetes and Weight Loss GLP-1 drugs, known for mimicking a hormone that regulates blood sugar, might have effects beyond managing diabetes and aiding in weight loss. Experts suggest that medications like semaglutide (Ozempic, Wegovy) and tilzepatide (Munjaro, Zepbound) could offer relief for those suffering from rheumatoid arthritis (RA). […]

Patients with obesity and additional health issues are the best candidates for weight-loss medications.

Patients with obesity and additional health issues are the best candidates for weight-loss medications.

Weight loss medications are gaining traction, and it’s estimated that the global market for these therapies could hit $150 billion by 2035. Drugs like GLP-1 agonists—semaglutide-based options such as Ozempic, Wegovy, Mounjaro, and Zepbound—are primarily designed to treat type 2 diabetes and manage obesity. Interestingly, recent research suggests additional benefits that doctors are beginning to […]